A METHOD OF TREATING TRANSIENT ISCHEMIC ATTACK CARDIOEMBOLIC GENESIS

摘要

A method of treating transient ischemic attack cardioembolic genesis includes the use of drugs. Determine cardioembolic pathogenic subtype of transient ischemic attack and prescribed antiarrhythmic drugs in a dose of 100 mg orally under the control of heart rate, warfarin to achieve an INR of 2.5 (2-3) in patients with artificial heart valves, anticoagulation with warfarin with a target INR of 3 (2,5-3 5) tserakson 1000 mg per 200 ml of physiological sodium chloride solution one time a day intravenously for 5-7 days, followed by 500 mg intramuscularly 7-10 days, L-lysine 10 mL aescinat intravenously 3-7 days.